Significance of antidonor blood type antibody for long-term graft acceptance in ABO-incompatible kidney transplantation.
Hadano
T
T
Department of Nephrology, Toho University School of Medicine, Tokyo, Japan.
Ohara
T
T
Aikawa
A
A
Hasegawa
A
A
D000017:ABO Blood-Group System / Q000276:immunology*; D000293:Adolescent; D000328:Adult; D001707:Biopsy, Needle; D001787:Blood Group Incompatibility; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009679:Nuclear Family; D010951:Plasma Exchange; D010956:Plasmapheresis; D012189:Retrospective Studies; D013997:Time Factors
D000017:ABO Blood-Group System; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D007518:Isoantibodies